Abstract
Previous chapters have shown that women with an increased susceptibility to breast cancer can be recognised by certain characteristics in their life history which may indicate factors capable of promoting or stimulating breast cancer growth. Measures taken to avoid or counteract these factors in a susceptible woman may arrest progression to frank cancer and lead to dormancy in the growth. This may enable her to live out her natural span of life before the cancer can manifest clinically, and in this sense is equivalent to prevention of the disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tokunaga, M., Norman, J.E., Asano, M. et al. (1979). Malignant breast tumours among atomic bomb survivors. J. Nat. Cancer Inst., 62 1347–1359.
Roberts, A.B., Anzano, M.A., Wakefield, L.M. et al. (1985). Type B transforming growth factor. A bifunctional regulator of cellular growth. Proc. Nat. Acad. Sci., 82, 119–123.
Sainsbury, J.R.C., Farndon, J.R., Sherbet, G.V., Harris, A.L. (1985). Epidermal growth factor receptor and oestrogen receptors in human breast cancer. Lancet, i, 364–366.
Garcia, M., Salazar, R.G., Pages, A. et al. (1986). Distribution of 52K oestrogen regulated protein in benign breast disease and other tissue by immunohistochemistry. Cancer Res., 46, 3734–3738.
Ohuchi, N., Thor, A., Page, D.L. et al. (1986). Expression of 21K ras protein in a spectrum of benign and malignant human mammary tissues. Cancer Res., 46, 2511–2519.
Haggie, J.A., Sellwood, R.A., Howell, A. et al. (1987). Fibroblasts from relatives of patients with hereditary breast cancer show fetal-like behaviour in vitro. Lancet, i, 1455–1457.
Wynder, E.L., MacCornack, F.A., Stellman, S.D. (1978). Epidemiology of breast cancer in 785 United States Caucasian women. Cancer, 41, 2341–2354.
MacMahon, B., Cole, P., Brown, J.B. (1973). Etiology of human breast cancer; a review. J. Nat. Cancer Inst., 50, 21–42.
Lemon, H.M. (1987). Antimammary carcinogenic activity of estriol. Cancer, 60, 2873–2881.
Trichopoulos, D., MacMahon, B., Cole, P. (1972). Menopause and breast cancer risk. J. Nat. Cancer Inst., 48, 605–611.
Frisch, R.E., Wyshak, G., Albright, N.L. et al. (1985). Lower prevalence of breast cancer among former college athletes. Brit. J. Cancer, 52, 885–891.
Byers, T., Graham, S, Rzepka, T. et al. (1985). Lactation and breast cancer; evidence for a negative association in premenopausal women. Amer. J. Epidem., 121, 664–674.
McTiernan, A., Thomas, D.B. (1986). Evidence for a protective effect of lactation on risk of breast cancer in young women. Amer. J. Epidem, 124, 353–358.
Cuzick, J., Wang, D.Y., Bulbrook, R.D. (1986). The prevention of breast cancer. Lancet, i, 83–86.
Gazet, J.C., (1985). Tamoxifen prophylaxis for women at high risk of breast cancer. Lancet, ii, 1119.
Auger, M.J., Mackie, M.J. (1988). Effects of tamoxifen on blood coagulation. Cancer, 61, 1316–1319.
Jordan, V.C. (1988). Antiestrogens in Cancer Treatment. In Stoll, B.A. (ed.), Endocrine Management of Breast Cancer, vol 2, S. Karger, Basel, 57–64.
Wong, W. (1986). Tamoxifen prophylaxis. Lancet, i, 264.
Muss, H.B., Smith, L.R., Cooper, M.R. (1987). Tamoxifen rechallenge; response to tamoxifen following relapse. J. Clin. Oncol., 5, 1556–1558.
Michnovicz, J.J., Hershcopf, R.J., Naganuna, H. et al. (1986). Increased 2-hydroxylation of estradiol as a possible mechanism for the antiestrogenic effect of cigarette smoking. N. Engl. J. Med., 315, 1305–1309.
Lawrence, C., Tessaro, J., Durgerian, S. et al. (1987). Smoking, body weight and early stage endometrial cancer. Cancer, 59, 1665–1669.
Thomas, D.B., Chu, J. (1986). Nutritional and endocrine factors in reproductive organ cancers. J. Chron. Dis., 39, 1031–1050.
Mettlin, C. (1984). Diet and epidemiology of human breast cancer. Cancer, 53, 605–611.
Katsouyanni, K., Willett, W., Trichopoulos, D. et al. (1988). Risk of breast cancer among Greek women in relation to nutrient intake. Cancer, 61, 181–185.
Marubini, E., Decarli, A., Costa, A. et al. (1988). The relationship of dietary intake and serum levels of retinol and beta carotene with breat cancer. Cancer, 61, 173–180.
Costa, A., Veronesi, U., Marubini, E. et al. (1987). Prevention of contralateral breast cancer with Fenretinide (personal communication).
Eisman, J.A., Martin, Ti., Maclntyre, I., Moseley, J.M. (1979). 1,25-Dihydroxy-vitamin D receptor in breast cancer cells. Lancet, ii, 1335–1336.
Frampton, R.J., Ormond, S.A., Eisman, J.A. (1983). Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D. Cancer Res., 43, 4443–4447.
McKenna, R.J. (1983). Applied cancer prevention in practice. Cancer, 51, 2430–2439.
Wolmark, N. (1983). Minimal breast cancer: a major therapeutic dilemma. In Margolese, R.G. (ed.), Breast Cancer, Churchill Livingstone, New York, 123–150.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Stoll, B.A. (1989). Prospects for Breast Cancer Prevention. In: Stoll, B.A. (eds) Women at High Risk to Breast Cancer. Developments in Oncology, vol 57. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1327-1_10
Download citation
DOI: https://doi.org/10.1007/978-94-009-1327-1_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7091-1
Online ISBN: 978-94-009-1327-1
eBook Packages: Springer Book Archive